横浜市立大学大学院 医学研究科 幹細胞免疫制御内科学血液・リウマチ・感染症内科

MENU

業績

2023年

膠原病グループ

原著論文: 症例報告を含む

  1. Adachi S, Takase-Minegishi K, Maeda A, et al: Risk of macrophage activation syndrome in patients with adult-onset Still’s disease treated with IL-1 and IL-6 inhibitors: A meta-analysis and single-center experience. Rheumatol Ther, 10(6): 1623-1636, 2023. DOI: 10.1007/s40744-023-00600-x.
  2. Hidekawa C, Yoshimi R, Saigusa R, et al: Protective effect of hydroxychloroquine on infections in patients with systemic lupus erythematosus: an observational study using the LUNA registry. Front Immunol, 14: 1227403, 2023.
  3. Higashitani K, Takase-Minegishi K, Yoshimi R, et al: Benefits and risks of hematopoietic stem cell transplantation for systemic sclerosis: a systematic review and meta-analysis. Mod Rheumatol, 33(2): 330-337, 2023.
  4. Ichikawa T, Kishida D, Shimojima Y, et al: Impact of online health information-seeking behavior on shared decision-making in patients with systemic lupus erythematosus: The TRUMP2-SLE project. Lupus, 32(11): 1258-1266, 2023.
  5. Katayama Y, Miyawaki Y, Shidahara K, et al: Association of alcohol consumption and fatigue in SLE: A cross-sectional study from Lupus Registry of Nationwide Institution (LUNA) cohort. Lupus, 32(4): 531-537, 2023.
  6. Kunishita Y, Ichikawa K, Uzawa Y, et al: Efficacy and safety of abatacept in patients with rheumatoid arthritis with previous malignancy. Ther Adv Musculoskelet Dis, 15:1759720X231186874, 2023. DOI: 10.1177/1759720X231186874.
  7. Kunimoto H, Miura A, Maeda A, et al: Clinical and genetic features of Japanese cases of MDS associated with VEXAS syndrome. Int J Hematol, 118(4): 494-502, 2023.
  8. Kurita N, Oguro N, Miyawaki Y, et al: Trust in the attending rheumatologist, health-related hope, and medication adherence among Japanese systemic lupus erythematosus patients. Rheumatology (Oxford), 62(6): 2147-2153, 2023
  9. Maeda A, Takase-Minegishi K, Kirino Y, et al: Immune checkpoint inhibitor-induced arthralgia is tightly associated with improved overall survival in cancer patients. Rheumatology (Oxford), 62(4): 1451-1459, 2023.

  10. Maeda A, Tsuchida N, Uchiyama Y, et al: Efficient detection of somatic UBA1 variants and clinical scoring system predicting patients with variants in VEXAS syndrome. Rheumatology (Oxford), 29(6): 268-274, 2023.
  11. Miyawaki Y, Sada KE, Shidahara K, et al: The association of grit with burnout components (professional efficacy, exhaustion, and cynicism) among academic rheumatologists: the TRUMP 2 -SLE study. J Clin Rheumatol, 29(6): 268-274, 2023.
  12. Miyoshi Y, Kise T, Morita K, et al: Long-term remission of VEXAS syndrome achieved by a single course of CHOP therapy: A case report. Mod Rheumatol Case Rep, 8(1): 199-204,2023.
  13. Nagafuchi H, Kikuchi H, Ishibash H, et al: Recommendations for the management of the vascular involvement in Behçet’s disease by the Japanese National Research Committee for Behçet’s disease-secondary publication. Mod Rheumatol, 34(1): 182-193, 2023.
  14. Oguro N, Yajima N, Miyawaki Y, et al: Effect of communicative and critical health literacy on trust in physicians among patients with systemic lupus erythematosus (SLE): the TRUMP2-SLE project. J Rheumatol, 50(5): 649-655, 2023.
  15. Ohashi T, Takase-Minegishi K, Maeda A, et al: Incidence and risk of hematological adverse events associated with immune checkpoint inhibitors: a systematic literature review and meta-analysis. J Hematol, 12(2): 66-74, 2023.
  16. Sada KE, Miyawaki Y, Shidahara K, et al: Grit personality of physicians and achievement of treatment goals in patients with systemic lupus erythematosus. Rheumatology (Oxford), 62(6): 2154-2159, 2023.
  17. Samukawa S, Yoshimi R, Kojitani N, et al: Cryptococcal meningitis with atypical paradoxical inflammatory reactions after antifungal treatment in acquired immune deficiency syndrome: A case report. J Infect Chemother, 29(3): 347-352, 2023.
  18. Yanai R, Yajima N, Oguro N, et al: Number of attending physicians and accumulated organ damage in patients with systemic lupus erythematosus: LUNA registry cross-sectional study. Rheumatol Ther, 10(2): 421-431, 2023.
  19. Yamaguchi H, Kobayashi D, Nakamura G, et al: Acute heart failure due to left common iliac arteriovenous fistula: A case of VEXAS syndrome. Mod Rheumatol Case Rep, 7(1): 327-333, 2023.
  20. 加藤 浩之, 水野 広輝, 東谷 佳奈, 等: 肺多発結節影を呈したVEXAS症候群の一例.関東リウマチ, 55: 62-65, 2023.

総説

  1. Yoshimi R, Nakajima H: Subcutaneous Edema in Polymyositis and Dermatomyositis. Intern Med. 62(15): 2161-2162, 2023.
  2. Yoshimi R, Nakajima H: COVID-19 vaccination and the development of autoimmune diseases. Intern Med. 62(10): 1387-1388, 2023.
  3. 桐野 洋平: 新しい自己炎症性疾患VEXAS症候群の最新の知見. 日本臨床皮膚科医会雑誌, 40(6): 722-726, 2023.
  4. 桐野 洋平: VEXAS 症候群を含めた 「後天性自己炎症性疾患」の臨床的課題. 炎症と免疫, 31(6), 2023.
  5. 桐野 洋平: VEXAS症候群ってどんな病気? 皮膚アレルギーフロンティア, 21(1): 36-37, 2023.
  6. 桐野 洋平: VEXAS症候群を疑う患者像について. 日本医事新報, 5165: 54, 2023.
  7. 吉見竜介, 栗田宜明, 矢嶋宣幸: 【レジストリ,コホートを用いた疫学的研究】全身性エリテマトーデス診療におけるshared decision making.リウマチ科, 69(6): 653-659, 2023.
  8. 吉見竜介: 各種難病の最新治療情報 成人スチル病の診断,治療,病態および療養上の注意.難病と在宅ケア. 29(7): 46-50, 2023.

著書

  1. 平原 理紗,桐野 洋平: 現場がエキスパートに聞きたい ベーチェット病. 日本医事新報社,162-167, 2023.
  2. 桐野 洋平: 抗リン脂質抗体症候群. 今日の治療指針, 95-96,2023.

検索 ページトップへ